Stifel Reiterates Buy Rating on Illumina (ILMN)

Go back to Stifel Reiterates Buy Rating on Illumina (ILMN)

Kent Lake Nominates Three Highly Qualified, Independent Candidates for Quanterix Board

March 3, 2025 8:00 AM EST

Believes Incumbent Boards Approval and Ongoing Pursuit of Reckless and Dilutive Proposed Merger with Akoya Biosciences Demonstrates Urgent Need for Refreshment

Nominees Would Bring Deep Healthcare and Financial Experience Necessary to Properly Oversee a Standalone Quanterix, Prevent Further Capital Misallocation and Improve Shareholder Value

Kent Lake Urges Shareholders to Vote Against Merger with Akoya to Protect the Future Value of Their Investment

RINCON, Puerto Rico--(BUSINESS WIRE)-- Kent Lake PR LLC (Kent Lake), a holder of 6.9% of the outstanding common stock of Quanterix Corporation (Quanterix or the... More